Bone Therapeutics and its collaborators Cerhum, 3D-Side, mSKIL and IREC awarded €3 million in funding under the framework of BioWin, the health cluster of Wallonia, to develop personalized, tissue engineered bone implants

• Bone Therapeutics announces the start of a new research collaboration with Cerhum, 3D-Side, mSKIL, and IREC due to recently awarded funding of €3M
• The funding was provided by Minister Willy Borsus, Vice-President of Wallonia, Belgium and Minister of Economy, Research and Innovation, Digital Technology, and Agriculture and Regional Planning
• The collaborators with Bone Therapeutics have been established under the name “BioWin” and are made up of experts of and academic partners for the specialized industry dedicated to developing personalized, tissue engineered bone implants
• The research will investigate and develop biologically active, patient-tailored, 3D printed, bioresorbable implants using Bone Therapeutics’ differentiated bone forming cells called ALLOB
• The collaboration projects a duration of 28 months for this research under the name TrueBone3D and plans to use the bone implants to replace bone transplants harvested from patient’s own bones
• TrueBone3D hopes to provide an alternative to bone autographs and to investigate the safety and effectiveness of bone implants as a treatment option for non-union fractures